A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study
2024 · Clinical Cancer Research · 6 citations
https://doi.org/10.1158/1078-0432.ccr-24-2113